BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 9549846)

  • 1. Prenatal ultrasound observations in subsequent pregnancies with Perlman syndrome.
    van der Stege JG; van Eyck J; Arabin B
    Ultrasound Obstet Gynecol; 1998 Feb; 11(2):149-51. PubMed ID: 9549846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perlman syndrome: report, prenatal findings and review.
    Alessandri JL; Cuillier F; Ramful D; Ernould S; Robin S; de Napoli-Cocci S; Rivière JP; Rossignol S
    Am J Med Genet A; 2008 Oct; 146A(19):2532-7. PubMed ID: 18780370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perlman syndrome--a cause of enlarged, hyperechogenic kidneys.
    Chitty LS; Clark T; Maxwell D
    Prenat Diagn; 1998 Nov; 18(11):1163-8. PubMed ID: 9854726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased nuchal translucency and other ultrasound findings in a case of simpson-golabi-behmel syndrome.
    Li CC; McDonald SD
    Fetal Diagn Ther; 2009; 25(2):211-5. PubMed ID: 19372699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beckwith-Wiedemann syndrome with overlapping Perlman syndrome manifestation.
    Ferianec V; Bartova M
    J Matern Fetal Neonatal Med; 2014 Oct; 27(15):1607-9. PubMed ID: 24215131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pregnancy outcome following ultrasound diagnosis of macrosomia.
    Delpapa EH; Mueller-Heubach E
    Obstet Gynecol; 1991 Sep; 78(3 Pt 1):340-3. PubMed ID: 1876361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enlarged nuchal translucency and low serum protein concentrations as possible markers for Zellweger syndrome.
    de Graaf IM; Pajkrt E; Keessen M; Leschot NJ; Bilardo CM
    Ultrasound Obstet Gynecol; 1999 Apr; 13(4):268-70. PubMed ID: 10341407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of nondiabetic macrosomia with Simpson-Golabi-Behmel syndrome: antenatal sonographic findings.
    Yamashita H; Yasuhi I; Ishimaru T; Matsumoto T; Yamabe T
    Fetal Diagn Ther; 1995; 10(2):134-8. PubMed ID: 7794515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of first-trimester nuchal translucency on second-trimester maternal serum biochemical screening for Down's syndrome.
    Thilaganathan B; Slack A; Wathen NC
    Ultrasound Obstet Gynecol; 1997 Oct; 10(4):261-4. PubMed ID: 9383877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fetal outcome in nuchal translucency with emphasis on normal fetal karyotype.
    Cha'ban FK; Van Splunder P; Los FJ; Wladimiroff JW
    Prenat Diagn; 1996 Jun; 16(6):537-41. PubMed ID: 8809895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Massive increase of foetal abdominal circumference due to hereditary polycystic kidney disease].
    Dukic L; Schaffelder R; Schaible T; Sütterlin M; Siemer J
    Z Geburtshilfe Neonatol; 2010 Jun; 214(3):119-22. PubMed ID: 20574939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening efficacy of the subcutaneous tissue width/femur length ratio for fetal macrosomia in the non-diabetic pregnancy.
    Rotmensch S; Celentano C; Liberati M; Malinger G; Sadan O; Bellati U; Glezerman M
    Ultrasound Obstet Gynecol; 1999 May; 13(5):340-4. PubMed ID: 10380299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rare clinical entity Perlman syndrome: is cholestasis a new finding?
    Demirel G; Oguz SS; Celik IH; Uras N; Erdeve O; Dilmen U
    Congenit Anom (Kyoto); 2011 Mar; 51(1):43-5. PubMed ID: 20726997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The implementation of first-trimester scanning at 10-13 weeks' gestation and the measurement of fetal nuchal translucency thickness in two maternity units.
    Pandya PP; Goldberg H; Walton B; Riddle A; Shelley S; Snijders RJ; Nicolaides KH
    Ultrasound Obstet Gynecol; 1995 Jan; 5(1):20-5. PubMed ID: 7850584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural history of trisomy 21 fetuses with increased nuchal translucency thickness.
    Pandya PP; Snijders RJ; Johnson S; Nicolaides KH
    Ultrasound Obstet Gynecol; 1995 Jun; 5(6):381-3. PubMed ID: 7552798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First-trimester fetal nuchal translucency thickness and risk for trisomies.
    Pandya PP; Brizot ML; Kuhn P; Snijders RJ; Nicolaides KH
    Obstet Gynecol; 1994 Sep; 84(3):420-3. PubMed ID: 8058241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyhydramnios and perinatal outcome.
    Phelan JP; Park YW; Ahn MO; Rutherford SE
    J Perinatol; 1990 Dec; 10(4):347-50. PubMed ID: 2277279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for Down's syndrome by fetal nuchal translucency measurement in a general obstetric population.
    Pajkrt E; van Lith JM; Mol BW; Bleker OP; Bilardo CM
    Ultrasound Obstet Gynecol; 1998 Sep; 12(3):163-9. PubMed ID: 9793187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Screening for Down syndrome using first-trimester combined screening followed by second trimester ultrasound examination in an unselected population].
    Rozenberg P; Bussières L; Chevret S; Bernard JP; Malagrida L; Cuckle H; Chabry C; Durand-Zaleski I; Bidat L; Lacroix I; Moulis M; Roger M; Jacquemot MC; Bault JP; Boukobza P; Boccara P; Vialat F; Giudicelli Y; Ville Y
    Gynecol Obstet Fertil; 2007 Apr; 35(4):303-11. PubMed ID: 17350315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The role of echography in the management of fetal macrosomia].
    Rosati P; Exacoustos C
    Minerva Ginecol; 1995 Jun; 47(6):245-50. PubMed ID: 7478092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.